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ORIGINAL ARTICLE
The use of synthetic cannabinoid receptor agonists (SCRAs) within the homeless
population: motivations, harms and the implications for developing an
appropriate response
Paul Graya, Rob Ralphsa and Lisa Williamsb
aDepartment of Sociology, Manchester Metropolitan University, Manchester, UK; bDepartment of Criminology, University of Manchester,
Manchester, UK
ABSTRACT
Background: Synthetic cannabinoid receptor agonists (SCRAs) have become increasingly associated
with a range of physical, mental health and societal harms. In response, several countries have intro-
duced legislation aimed at restricting their supply and use. While these legislative changes have led to
a decrease in SCRA use within the general population, SCRAs remain popular within vulnerable popula-
tions, in particular the homeless. This article presents the findings from the first in-depth qualitative
study of SCRA use within the homeless population. It makes an important and timely contribution to
the current evidence base and discourse on how governments and service providers should respond
to SCRA use within the homeless population.
Methods: The research on which this article is based was undertaken in Manchester, UK. Qualitative
interviews were undertaken with 53 homeless users of SCRAs and 31 stakeholders.
Results: The motivations for SCRA use are broadly similar to those associated with traditional drugs;
namely to escape from the reality of life on the streets, and to provide relief from the physical condi-
tions of a street-based lifestyle. However, the combination of their low cost, the ease with which they
can be accessed, their high potency, and their non-detectability explains their particular appeal to the
homeless population. Alongside these motivations, the research identified a range of physical, mental
health, and societal harms that were directly attributable to SCRAs.
Conclusions: The most appropriate way to address the continued use of SCRAs within the homeless
population is through the development of a more appropriate service response rather than further
legislative change.
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Introduction
Synthetic cannabinoid receptor agonists (SCRAs) first
emerged in the mid-2000s. Produced with manufactured
chemicals, SCRAs were developed to create similar effects to
THC (Delta-9 tetrahydrocannabinol), the active ingredient
in cannabis (Fantegrossi et al. 2014; Abdulrahim and
Bowden-Jones 2016). Despite their initial popularity with
recreational substance users, perceptions of SCRAs have
since become more negative (Bilgrei 2016; Blackman and
Bradley 2017), with users reporting adverse physical and
mental health effects associated with their use (Winstock
and Barratt 2013; Soussan and Kjellgren 2014; Winstock
et al. 2017). Health harms associated with SCRA use have
been identified in several countries, including Australia
(Barratt et al. 2013), Germany (Zimmermann et al. 2009),
New Zealand (Every-Palmer 2011), the United Kingdom
(HM Inspectorate of Prisons 2014, 2015, 2016; Prisons and
Probation Ombudsman 2015; Ministry of Justice 2016;
Ralphs et al. 2017), and the United States (Castellanos et al.
2011; Van der Veer and Friday 2011; Bebarta et al. 2012;
Thomas et al. 2012; Harris and Brown 2013; Trecki et al.
2015). Furthermore, SCRAs have been directly implicated in
60 deaths in England and Wales in 2018 (ONS 2019a), more
than 100 deaths in Europe in 2016–17 (EMCDDA 2018a),
and 75 deaths in New Zealand between 2017 and 2019
(Doyle 2019). Alongside these health harms, high profile
media coverage of SCRA users in ‘zombie-like states’ in
major cities around the world (Rosenburg and Schweber
2016; Williams 2017; Alexandrescu 2019) has driven public
and political demand for a response to SCRAs (Jones 2018).
To date, the response has largely been in the form of legisla-
tion rather than service reform, with a number of countries
(including Ireland, New Zealand, Poland, and the UK)
implementing prohibition policies aimed at restricting the
supply and use of SCRAs (Department of Justice and
Equality 2010; Malczewski 2011; Parliamentary Counsel
Office 2013; Home Office 2016).
However, while these legislative changes have led to a
decrease in SCRA use within the general population (Home
Office 2018a), SCRAs have remained popular among
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prisoners and the homeless (Abdulrahim and Bowden-Jones
2016; MacLeod et al. 2016; EMCDDA 2018b; Home Office
2018b; Ministry of Housing, Communities and Local
Government 2018; UNODC 2018). In seeking to understand
the continuing popularity of SCRAs within these vulnerable
populations, a small body of research has investigated the
specific motivations and harms associated with SCRA use
within the prison population in the UK (Centre for Social
Justice 2015; McBride 2016; User Voice 2016; Ralphs et al.
2017). This has resulted in the development of a tailored
service response, in the form of a toolkit for prison staff
(Public Health England 2017), alongside a criminal justice
strategy aimed at restricting the supply of SCRAs within the
secure estate (HM Prison and Probation Service 2019). In
contrast, despite SCRA use within the homeless population
being highlighted as a major public health concern that
demands empirical research (Home Office 2018a), there is
currently no comparable research on which to build an evi-
denced-based response to SCRA use within the homeless
context. This article begins to fill this gap in the current
knowledge and evidence base.
The extant literature on substance use within the homeless
population consists largely of studies that were undertaken
prior to the rise in popularity of SCRAs, when the most com-
monly used illicit substances were cannabis, heroin and crack
cocaine (see, for example, Klee and Reid 1998a, 1998b;
Fountain and Howes 2002; Baer et al. 2003; Fountain et al.
2003; Gomez et al. 2010). These studies found that a large pro-
portion of homeless substance users are dependent on the sub-
stances they use (Chen et al. 2006; Martijn and Sharpe 2006;
Thompson et al. 2009); largely because of the functional pur-
pose they serve. These include alleviating the stress of life on
the streets (Klee and Reid 1998a, 1998b; Thompson 2005),
helping users to keep warm (Ayerst 1999), and/or to self-medi-
cate the symptoms of physical and mental health problems
(Klee and Reid 1998a, 1998b; Fountain and Howes 2002;
Homeless Link 2014). The question of whether or not the
motivations for SCRA use within a homeless context differ
from those identified in studies conducted prior to the advent
of SCRAs is currently unknown. Where motivations for SCRA
use have been investigated, this has predominantly focused on
the general population and the prison population. Within the
general population, SCRAs have been identified as a cheap and
legal alternative to cannabis (Kronstrand et al. 2013; Winstock
and Barratt 2013; European Commission 2014; Blackman and
Bradley 2017; Winstock et al. 2017). While studies within the
prison population have found the non-detectability of SCRAs
in mandatory drug tests (MDTs), and their ability to help users
escape from reality and kill time, as key motivators for use
(Centre for Social Justice 2015; McBride 2016; User Voice
2016; Ralphs et al. 2017). With these varying motivations for
use in mind, it is imperative that a more in-depth understand-
ing of the motivations for SCRA use within the particular con-
text of homelessness is developed. Without this, the reason/s
for the apparent ineffectiveness of prohibition policies to
address SCRA use within the homeless population will remain
unclear. By forefronting the seldom-heard voices of this often
excluded and marginalized population, this article sets out to
elucidate the specific motivations for the use of SCRAs within
the homeless population.
Methodology
Research context
The research on which this article is based (Ralphs et al. 2016)
was undertaken in Manchester, UK. From the mid-2010s,
media reports started to draw attention to ‘Spice epidemics’ in
a number of major UK cities, of which Manchester was one.
Indeed the mainstream media has repeatedly highlighted the
devastating impact of SCRA use within the homeless popula-
tion in Manchester (see, for example, VICE 2015; BBC 2016;
UNILAD 2018; Alexandrescu 2019). However, as Alexandrescu
(2019, p. 7) asserts, much of this stigmatizing media coverage
has ignored the ‘lived experiences and suffering of those whose
lives are scarred by poverty and substance abuse’. To ensure
that the local service response fully met the complex needs of
homeless SCRA users, Manchester’s Community Safety
Partnership Board commissioned the research team to investi-
gate the scale and nature of SCRAs use within the homeless
population, and to make recommendations on how to improve
user engagement and reduce user and societal harms. The
research took place between January and June 2016. The find-
ings presented in this article draw on 84 qualitative interviews
with homeless users of SCRAs and stakeholders that support,
work with, and/or engage with this particular population. The
interviews were supplemented by regular observational research
throughout the 6-month study.
Participants
For the purposes of the research, we used the term homeless
to include both street homeless, and those non-street home-
less who were leading a street-based lifestyle at the time
(i.e. spending large portions of their day in Manchester city
center, primarily to obtain money to purchase substances
that they then used in public places around the city center).
Hence, in addition to street homeless, participants included
those living in a range of temporary accommodation, such
as hostels, night shelters, supported accommodation, proba-
tion bail hostels, and approved premises following release
from custody. Many of these non-street homeless partici-
pants had recent experience of being street homeless.
Using a purposive sampling approach, homeless SCRA
users were accessed through a range of local services who
acted as gatekeepers (Hammersley and Atkinson 1983), iden-
tifying suitable individuals for interview (in terms of both
knowledge and experience of SCRAs, and ability to fully
consent). Fifty-three interviews were undertaken with home-
less users of SCRAs. Fifty-one were current users of SCRAs,
and two reported recent desistance. Users were aged
between 16 and 52 years (n¼ 41 were aged 25 or above;
n¼ 12 were between the ages of 16 and 24), and the major-
ity (n¼ 47) were male. In terms of their substance use pro-
file, many of those interviewed would be classed as having a
‘severe substance use disorder’ (American Psychiatric
Association 2013). In addition, a further 31 interviews were
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undertaken with a range of relevant stakeholders that were
identified by the research team and the Manchester
Community Safety Partnership Board. These included, for
example, supported accommodation staff and managers,
practitioners from adult and young people’s substance use
treatment services, neighborhood police officers, Accident
and Emergency nurses and medical consultants, mental
health dual diagnosis nurses, homeless medical practice GPs,
staff from approved premises and probation bail hostels,
homeless day center staff, and homeless outreach workers.
Data collection
Both the university research and ethics governance commit-
tee, and Manchester City Council’s research governance
committee, granted ethical approval for the research. All
interviews were conducted face-to-face and digitally
recorded. The vast majority of user interviews were under-
taken on the premises of either local homeless services, or
supported accommodation providers. These included a med-
ical practice serving the homeless population, homeless day
centers, supported accommodation providers, and probation
hostels. In addition, a small number of interviews took place
in city center headshops1 and on the streets during the
observational research. The user interview schedule was
semi-structured with interviewees asked to talk about: the
access and availability of SCRAs in the city; the extent of
their SCRA use; the relationship between SCRAs and other
substances; their experiences of using SCRAs; their motiva-
tions for the onset, continuation and, where applicable,
desistance from SCRA use; and their views and experiences
of service provision.
Stakeholder interviews were predominantly conducted at
stakeholders’ places of work. A small number (e.g. for home-
less outreach workers and neighborhood police) were con-
ducted on university premises. The semi-structured
interview schedule for stakeholders focused on their know-
ledge and understanding of SCRA use, their experiences of
working with users, the impact of SCRAs on their organiza-
tion/service, and their professional observations on where/
how policy and practice could be improved. In addition to
the interviews with users and stakeholders, over a 150 hours
of observational research was carried out over the 6-month
period. The observational research was conducted in city
center headshops, homeless day centers, a medical practice
serving the homeless population, and city center ‘hot spots’
for SCRA use identified by neighborhood police and home-
less outreach workers.
All interviewees were provided with written and verbal
information about the research. Prior to interview, each par-
ticipant was required to sign a consent form. Participation in
the research was voluntary with no incentives offered
(Seddon 2005). To ensure anonymity, all participants were
assigned a depersonalized identifier. For users, this included a
unique code, gender, age band and accommodations status
(e.g. U29, male, early 20s, street homeless). For stakeholders,
this included a unique code and a broad description of their
role (e.g. U59, Young person’s homeless support worker). The
user interviews ranged in length from 21 to 129minutes.
Stakeholder interviews ranged from 38 to 86minutes.
Data analysis
All the interviews were transcribed verbatim and imported
into NVivo10, a qualitative data analysis software package
(QSR International 2019). The analysis was undertaken the-
matically (Braun and Clarke 2006), with a single structured
coding system created for both users and stakeholders
(Bazeley and Jackson 2013). The system comprised a hybrid
of both inductive (from the interviews) and deductive (from
the research questions) codes (Fereday and Muir-Cochrane
2006). All three authors undertook the analysis independently,
and the themes that iteratively arose were crosschecked, dis-
cussed and agreed upon (Neale et al. 2005). The agreed
themes were the extent of SCRA use, the ease of access to
SCRAs, their low cost, the motivations for the onset and con-
tinuation of use, and the harms connected to the use of
SCRAs. These themes structure the following findings.
Setting the scene: the extent of SCRA use, ease of
access, and value for money
Before making our argument about the motivations for
using SCRAs, we begin by setting the scene and highlighting
the perceived scale of SCRA use within the homeless popu-
lation in Manchester. In line with research within the UK
prison population (Ralphs et al. 2017), the use of SCRAs
was reported to be widespread within the homeless popula-
tion in Manchester, regardless of whether users were living
on the streets or in temporary accommodation (see also
Alexandrescu 2019).
It’s everywhere, it’s absolutely everywhere. … It’s really rife
[among Manchester’s homeless]. (U29, male, early 20s,
street homeless)
The perception of many interviewees was that ‘everyone’ they
knew was using SCRAs. We recognize that this perception is
unsurprising; especially as the criteria for being included in the
study was being a current/recent SCRA user. As other research
has found, a relationship exists between a person’s substance use
and that of their social network (Kandel and Davies 1991; Latkin
et al. 1995; Klee and Reid 1998a; Costenbader et al. 2006;
Buchanan and Latkin 2008; Gomez et al. 2010). It is therefore
highly likely that the interviewees’ peers were users too, which no
doubt fed their perception that SCRAs were ‘everywhere’.
Nevertheless, those working directly with this population per-
ceived the use of SCRAs to be similarly widespread. For example,
it was common for homeless outreach workers and homeless
drop-in staff to note how the use of SCRAs was pervasive among
the people they were working with.
I’ve probably got about 40 clients on my caseload at the minute
who are street homeless. Of them, I’d say about 95 per cent of
them take Spice [SCRAs]. (U59, Young person’s homeless
support worker)
1Headshops are retail outlets that specialize in drugs paraphernalia typically
used for the consumption of cannabis and tobacco, and items related to
cannabis culture, as well as other substances and related countercultures.
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You’d be surprised how many [homeless] people [use SCRAs].
… I’d say 99 per cent of them are Spice heads [use SCRAs].
(U1, Homeless support worker)
Furthermore, it was reported that homeless substance
users were replacing the use of those substances traditionally
associated with this population (Klee and Reid 1998a, 1998b;
Fountain and Howes 2002; Baer et al. 2003; Fountain et al.
2003; Gomez et al. 2010) with SCRAs.
A lot of my friends have given up heroin and crack addictions,
and they now smoke the Spice [SCRAs]. I’m the same. I’ve
given up an alcohol, crack and heroin habit, and [now] I just
smoke Spice [SCRAs]. (U2, male, mid 20s, supported housing)
In the context of the perceived widespread use of SCRAs
within the homeless population in Manchester, we turn to
explore how SCRAs are accessed. The use of SCRAs was ini-
tially facilitated by the existing legal market that provided an
easily accessible supply. In the UK, prior to the introduction
of the Psychoactive Substances Act in May 2016, the majority
of local outlets that sold ‘legal highs’2 were typically located
in city centers. In Manchester, our observations in city cen-
ter headshops and newsagents found that they sold 1.0 or
1.5-g packets of SCRAs for £10. Many headshops and news-
agents also offered deals such as three packets for £20.
Thereby providing SCRA users with much more than a typ-
ical £20 street deal of cannabis, which would only contain
1.2–1.5 g of cannabis (Salinas 2014; DrugWise 2017).
Furthermore, due to the potency of SCRAs – with current
strains reportedly over 700 times more potent than cannabis
(Banister et al. 2015a; Banister et al. 2015b; Adams et al.
2017; HM Inspectorate of Probation and the Care Quality
Commission 2017) – a much smaller amount was required
to mix with tobacco per ‘joint’. Users reported they could
make between 20 and 40 joints from one packet when they
first started using, making SCRAs particularly appealing to
the economically disadvantaged homeless population.
Indeed, many homeless SCRA users we interviewed high-
lighted the ease of access to SCRAs and low price as primary
drivers for use.
I’m only smoking it [SCRAs] because it’s so readily available
and it’s cheaper than weed [cannabis]. (U52, male, mid 20s,
street homeless)
It’s more available than ever now [since the 2016 Psychoactive
Substances Act]. I don’t even have to move off my [begging]
spot no more. They [dealers] just serve it [SCRAs] up wherever
you’re sat. (U19, male, mid 20s, supported accommodation)
The ban [2016 Psychoactive Substances Act] hasn’t changed
anything, … it’s not stopping people from taking it [SCRAs],
you know what I mean, not at all. It’s just changed where
people get it from. (U17, female, late teens, street homeless)
As evidenced, despite the 2016 Psychoactive Substances
Act leading to the demise of high street outlets in the UK,
SCRAs remain easily accessible to the homeless population.
As was the case in Poland and Ireland (European
Commission 2014; McVeigh 2015; Bujalski et al. 2017),
rather than reducing use, tougher legislation has simply dis-
placed SCRAs from the high street to the illegal street mar-
ket (Gray and Ralphs 2016; Ralphs and Gray 2017; Home
Office 2018a). The continued availability of SCRAs can be
explained, in part, by the continued demand for SCRAs; a
demand driven largely by the main motivations for SCRA
use that we now outline.
The enduring popularity of SCRAs: motivations
for use
Given the unique and challenging environments the homeless
population find themselves in, it is important to explore the
specific motivations they have for using SCRAs. While ease of
access and value for money were key factors in facilitating the
onset and continued use of SCRAs among our sample, inter-
viewees outlined a number of specific motivations associated
with the use of SCRAs that accounted for their continued use
beyond the introduction of the 2016 Psychoactive Substances
Act. In line with existing research (see MacLeod et al. 2016;
User Voice 2016; Ralphs et al. 2017), these included their
non-detectable nature, their ability to provide an escape from
the reality of life on the streets, and to prevent the onset of
unpleasant withdrawal symptoms.
Mirroring the findings from research within the UK
prison population (Ralphs et al. 2017), SCRAs appealed to
our homeless sample because of their non-detectable nature.
Homeless users of SCRAs discussed being able to openly
consume these substances in public settings, and/or being
able to avoid detection (and therefore sanctions) in accom-
modation with zero tolerance substance use policies.
I can sit anywhere I want and blaze [smoke] a Spice [SCRA]
spliff and nobody, no police or anybody, can do anything ‘cos
they’ll never know. … No smell you see. (U40, male, mid 20s,
street homeless)
You see, in here now [bail hostel], to be honest, I can’t drink or
smoke weed [cannabis] and get away with it. You get
breathalysed when you come back in and they can smell the
skunk [cannabis] in your room. So instead of smoking weed,
… I smoke Spice [SCRAs]. (U43, male, late 30s, probation
bail hostel)
As researchers have found in other settings, the non-
detectability of SCRAs in MDTs is a key motivator for use
(Bebarta et al. 2012; Barratt et al. 2013; Perrone et al. 2013;
Ralphs et al. 2017). As noted, many of the SCRA users inter-
viewed for this study were living in temporary accommoda-
tion that had a zero tolerance policy to substance use.
Enforcement of this policy often involved MDTs. Our home-
less interviewees discussed how they were consuming SCRAs
to avoid a positive test.
The only reason I have Spice [SCRAs] is because I’m on a drugs
test for weed [cannabis]. … If I wasn’t on a drugs test, I
wouldn’t be smoking Spice [SCRAs]. (U42, male, mid 20s,
probation bail hostel)
The main thing is it [SCRAs] doesn’t show up in your blood
system whatsoever, like cannabis will, so that’s why people smoke
it [SCRAs]. (U38, male, mid 20s, probation approved premises)
2The term ‘legal highs’ was a widely used umbrella term in the UK to describe
new psychoactive substances such as SCRAs prior to the 2016 Psychoactive
Substances Act.
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The inability, at the time of our research, of MDTs to
detect SCRAs was corroborated by professionals working
with the homeless population, as illustrated by the following
extract from an interview with a member of staff at a proba-
tion approved premises.
Our drug tests show cannabis, benzos [benzodiazepines],
amphetamines, methamphetamines, opiates and cocaine. …
While I was actually testing him, he was clearly under the
influence of something – he could hardly sit up in his chair, he
was slurring his speech. … [But] he came back negative for
everything, which would probably indicate that he’s been using
legal highs [SCRAs]. (U31, Probation approved premises staff)
The non-detectability of SCRAs, particularly in MDTs,
for those living in probation accommodation or subject to
drug testing in other temporary accommodation, provides
clear evidence of the appeal of these substances beyond the
secure prison estate (see also Grace et al. 2019). It is evident
that the non-detectability of the smoking of SCRAs in public
places and temporary accommodation is an additional sig-
nificant factor in their appeal for those spending time in
public places and/or living in accommodation with zero tol-
erance policies toward substance use.
Other primary motivations identified for the use of
SCRAs revolved around the particular functions these sub-
stances could provide, especially in the context of homeless-
ness. A commonly cited motivation for the use of SCRAs
among our homeless interviewees was that they provided an
escape from the reality of their daily lives. Studies of SCRA
use within the secure prison estate highlight their functional
nature and how they are used as a ‘bird killer’ (User Voice
2016), to provide a ‘head shift’, and to ‘take away the bars’
(Ralphs et al. 2017, p. 63). In line with this small body of
prison research, homeless SCRA users discussed how SCRAs
offered respite from the day-to-day experience of life on the
streets, helping users to keep warm, forget problems, and/or
pass the time.
I know this might sound daft yeah, but when you are on the
streets and you smoke Spice [SCRAs], it makes you feel warm,
like you’ve got a warm blanket around you. (U27, male, mid
20s, street homeless)
Spice [SCRAs] makes this life [on the streets] bearable, you get
me? It numbs you. It just takes you out of your present
situation. When that situation is life on the streets, and that can
be fucking hard, then that makes it [SCRAs] a fucking perfect
drug for the homeless. (U8, male, mid 20s, street homeless)
Spice [SCRAs] makes life on the street fly. I worked out the
other day, I’ve been homeless now for over two and a half years,
it feels like a couple of months. That’s the Spice [SCRAs]. It
alters your perception of time and reality. (U48, male, early 20s,
street homeless)
In addition, those living on the streets recounted the dif-
ficulty they experienced in getting to sleep in public spaces
due to feelings of vulnerability. In this context, SCRAs func-
tioned to facilitate sleep.
It helps you sleep. [The] amount of times I’ve done that in the
car park I used to sleep in. Spice [SCRAs] knocks you to sleep.
(U28, male, early 20s, supported homeless accommodation, ex-
street homeless)
A spliff of Spice [SCRAs] knocks you out. [It’s] like being hit by
a truck. (U6, male, mid 20s, street homeless)
These findings are consistent with those from research
undertaken with homeless substance users prior to the rise
in popularity of SCRAs (see Klee and Reid 1998a, 1998b;
Fountain and Howes 2002; Baer et al. 2003; Fountain et al.
2003; Gomez et al. 2010). For example, these earlier studies
found that substances (most commonly cannabis, heroin
and crack cocaine) were used to alleviate the stress of life on
the streets (Klee and Reid 1998a, 1998b; Thompson 2005)
and to help users keep warm (Ayerst 1999). Indeed, Klee
and Reid (1998a, p. 132) noted how substances were used as
a coping strategy for ‘dampening pain, lifting mood, induc-
ing sleep and offering a protective mental anesthesia’ against
the stressors of life on the streets. When the effects of
SCRAs outlined above are combined with their low price
and the ease with which they can be accessed, the enduring
popularity of SCRAs becomes more understandable, despite
attempts to legislate against their use.
Green heroin? Addiction, dependency,
and tolerance
Research in the US has found that SCRAs are highly addict-
ive and have the potential to lead to severe dependency
(Zimmermann et al. 2009; Every-Palmer 2011). This is sup-
ported by UK prison research (Forward 2015; Ralphs et al.
2017), resulting in current UK clinical guidance acknowledg-
ing that ‘SCRAs have a potential for misuse and dependence’
(Abdulrahim and Bowden-Jones 2016, p. 11). In our study,
many of the homeless interviewees – who often reported
considerable lifetime experience of using heroin, crack
cocaine and a range of licit and illicit substances – consist-
ently described SCRAs as being more addictive than other
substances they had used.
Spice [SCRAs] is definitely the most addictive [substance]. (U46,
male, late 20s, street homeless)
It just rules your life. If you’ve not got your Spice [SCRAs],
bollocks to everything else, nothing matters in the world. (U32,
male, early 30s, street homeless)
I’m addicted to Annihilation [a popular SCRA]. … It’s stronger
than any other drug I’ve ever taken. (U9, male, early 30s,
street homeless)
In addition to the practical and functional reasons for
SCRA use outlined above, for many interviewees, their con-
tinued use of SCRAs was also motivated by a desire to avoid
the acute and unpleasant symptoms associated with with-
drawal. These included loss of appetite, hallucinations and
paranoia, excessive sweating, severe stomach cramps, diar-
rhea, and vomiting. During our fieldwork, it was common
for the research team to observe some of these symptoms
first hand, witnessing users visibly shaking, sweating pro-
fusely, and becoming agitated.
After a few weeks [of smoking SCRAs] I was waking up
sweating me back out and I had to smoke [SCRAs] just to stop
the sweating. (U25, male, early 20s, street homeless)
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It [withdrawing from SCRAs] is horrible. Hallucinations,
stomach cramps, shits, being sick, can’t eat nothing, paranoia,
everything. (U7, male, mid 30s, street homeless)
I’m an ex-heroin user and the feelings are the same [when
you’re withdrawing from SCRAs]. You get no sleep, hot and
cold sweats, spewing up, diarrhoea. It’s horrible. (U9, male, early
30s, street homeless)
In line with the last quote, professionals working with
this population frequently noted the similarities to heroin in
the way that SCRAs were negatively affecting users.
I see this drug [SCRAs] as almost a comparison to heroin, in
the way it’s affecting people. (U47, Supported housing staff)
Some [SCRA users] are aligning it to heroin withdrawals. So the
flu like symptoms, the stomach cramps, the sweating, the
irritation. (U72, Homeless day centre manager)
Despite the potent strains of SCRAs that were available
during the research period (see Banister et al. 2015a;
Banister et al. 2015b), some users reported quickly establish-
ing high levels of tolerance. Indeed, the research team fre-
quently witnessed homeless users putting around half a
gram of SCRAs into a single joint.
I first started at half a gram and I’d probably get about 30 spliffs
out of it. … Now I’m up to smoking seven grams [a day].
(U39, male, mid 20s, supported housing)
When I started smoking it, I only had to put a little bit in it.
… [But] by the time I was coming off it, I was putting half a
gram in a joint. (U11, male, early 20s, supported
accommodation)
As we have illustrated so far, there are a range of key
motivations for the onset and continued use of SCRAs
within this population. These include their potency, low
cost, accessibility, non-detectable nature, their ability to
enable users to escape the reality of life on the streets, and
to allay acute and unpleasant withdrawal symptoms.
Alongside these motivations, a consistent theme that arose
from the interviews was the harms – to individual users, the
homeless population, and wider society – that were directly
attributed to SCRA use.
Harms: physical, mental health, and societal
We have already outlined some of the physical harms associ-
ated with the use of SCRAs, i.e. the intense withdrawal symp-
toms. Other reported physical harms included weight loss.
I used to smoke [SCRAs] all day, every day. … I lost a lot of
weight. I looked like a crackhead, like a full on crackhead. (U6
Male, mid 20s, street homeless)
Alongside weight loss, and in line with other research
(see EMCDDA 2018a), interviewees reported often losing
consciousness and receiving emergency medical treatment
after using SCRAs. One of our interviewees discussed how
when she was using SCRAs daily, she was hospitalized three
or four times per week because of repeatedly losing con-
sciousness. Furthermore, SCRAs have also been linked to
deaths worldwide (EMCDDA 2018a; Doyle 2019; ONS
2019a). Our homeless interviewees were fully aware of the
risk of death connected to the use of SCRAs.
I want people to realise what it [SCRAs] is doing, know what I
mean? Like what it’s like. It’s killing us all. We’re slowly getting
killed. (U17, female, late teens, street homeless)
This risk should be understood in the context of a 25%
increase in deaths among the homeless population in the
last 5 years in England and Wales (ONS 2019b). In 2018,
there were an estimated 726 deaths of homeless people in
England and Wales, 129 (22%) more deaths than in 2017
(ONS 2019b). Furthermore, the ONS (2019b) reported that
drug-related deaths in England and Wales have reached an
all-time high. Deaths related to synthetic cannabinoids have
more than doubled from 24 in 2017 to 60 in 2018 (ONS
2019a). Most of our homeless interviewees were able to
recall at least one person they knew whose death they
believed was attributable to the use of SCRAs.
My mate died in front of me on it [SCRAs]. (U63, male, mid
30s, street homeless)
I’ve seen two people die off it, from having a fit through Spice
[SCRAs], and then not being able to come out of the fit. (U41,
male, mid 20s, sofa surfing)
I’ve actually seen someone die. Police were zapping him trying
to get him back to life. (U12, female, late teens, street homeless)
In addition to this physical risk, our homeless interviewees
also believed the use of SCRAs was negatively affecting their
mental health. Mental health problems are particularly preva-
lent within the homeless population (Homeless Link 2014). It
is important to acknowledge that many of our sample were
living in challenging environments (such as sleeping rough on
the city center streets) which could induce poor mental health
and/or aggravate existing mental health problems. It is there-
fore difficult to attribute any negative impact on users’ mental
health solely to the use of SCRAs. Nevertheless, in line with
other research, many of our interviewees were adamant that
their mental health problems had not existed prior to using
SCRAs (Castellanos et al. 2011), or if they had, the use of
SCRAs had exacerbated them (Every-Palmer 2011; Papanti
et al. 2013; Fattore 2016; MacLeod et al. 2016; Ralphs et al.
2017). For example, some of our interviewees discussed how
SCRAs had triggered a range of mental health problems.
Heavy bouts of psychosis and depression, crippling depression.
… It’s mad, proper crazy, like a whole different dimension.
(U18, male, mid 20s, supported accommodation)
I started hearing voices … I thought I could send messages and
that through my own mind without speaking. It was horrible.
(U14, male, early 30s, street homeless)
I don’t think I had anxiety before smoking Spice [SCRAs], I
really don’t. (U4, male, early 20s, supported accommodation, ex-
street homeless)
Others emphasized how SCRAs had aggravated preexist-
ing mental health problems.
I’ve got mental health problems anyway, previous to the Spice
[SCRA use], [but] the Spice [SCRAs] has amplified them. (U30
Male, mid 20s, Probation approved premises)
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I’ve got paranoia and anxiety [anyway] but it [SCRAs] makes it
a lot worse. (U57, male, early 20s, street homeless)
In addition to the physical and mental health harms
described above, a range of societal harms were identified. As
previously discussed, some interviewees reported quickly
building up tolerance to SCRAs that resulted in them using
large quantities per day. Others noted how they needed to
use SCRAs daily to prevent the onset of acute and unpleasant
withdrawal symptoms. Consequently, despite SCRAs being
relatively cheap to buy, interviewees reported spending up to
£50 a day on SCRAs; an amount similar to that required to
fund a heroin and/or crack cocaine dependency (Harocopos
et al. 2003; Bennett and Holloway 2008). Many of those inter-
viewed for this study described committing offenses – ranging
from low-level acquisitive crime to more serious violence – to
fund, or partially fund, their daily use of SCRAs.
The majority of people [users] have to commit crimes. The
others sit down and beg. (U51, male, mid 20s, sofa surfing and
street homeless)
[So people are committing crime… ?] Yeah, a lot. Shoplifting,
car theft, robbing. I’ve seen people do all sorts. (U36, male, mid
30s, street homeless)
Some female interviewees also described how they had
become involved in sex work to pay for SCRAs.
I’ve got to prostitute myself tonight because I owe people a lot
of money [for SCRAs], a lot of money. (U17, female, late teens,
street homeless)
Some of the main motivations our homeless interviewees
identified for using SCRAs – such as to avoid detection in
MDTs, to make life on the streets tolerable, and to fend off
withdrawal symptoms – have made SCRAs highly valued
within this population, particularly through the night when
access was limited. In the US, Bourgois (2009) characterized
the homeless heroin user population as one which looks out
for, and supports, each other. In sharp contrast, our inter-
viewees frequently told us about occasions when homeless
SCRA users were victims of crime committed by other
homeless users of SCRAs. Many of our homeless interview-
ees recalled how quickly they, or users they knew, would get
agitated, aggressive and violent if they were unable to obtain
SCRAs, and would use violence as a means to acquire them.
If they’ve not got it [SCRAs], they’ll stab you for it, they’ll batter
you for it. (U34, male, late 20s, street homeless)
They’re slashing people up. That’s how far people are willing to
for Spice [SCRAs]. (U76, male, mid 20s, street homeless)
Yet, by doing so, those involved in committing these
crimes were perceived to be transgressing an unspoken code.
We [the homeless population] used to stick by each other, we
used to be literally like “If someone messes with you, you got to
mess with all of us”. … And now we’re lifting [stealing from]
each other for the Spice [SCRAs]. (U26, female, late teens,
street homeless)
People [in the homeless population] do things [now] that they
would never have done, … like rob off your friends. … And
you know you’re leaving him sweating tonight because you’re
taking it [SCRAs]. But I need it. Either he’s sweating, or I’m
sweating. (U32, male, early 20s, street homeless)
Discussion and conclusions
By endeavoring to provide a platform for the voices of
marginalized homeless users of SCRAs – voices that are too
often absent from current discourses on SCRA use – this
article highlights the reasons why SCRAs remain popular
and widely available within the homeless population, despite
the introduction of legislation aimed at restricting their sup-
ply. In line with previous studies on substance use and
homelessness, this article has demonstrated that the motiva-
tions for SCRA use are broadly similar to those associated
with cannabis, heroin and crack cocaine; namely to escape
from the reality of life on the streets, and to provide relief
from the physical conditions of a street-based lifestyle.
However, when compared to cannabis, heroin and crack
cocaine, the combination of the low cost of SCRAs, the ease
with which they can be accessed, their high potency, and
their non-detectability (in both public places and temporary
accommodation) explains their particular appeal to the eco-
nomically disadvantaged homeless population.
While this helps to explain the enduring popularity of
SCRAs within the homeless population, another key finding
is the unique set of harms associated with SCRA use within
this population. In contrast to earlier studies that identified
the use of cannabis, heroin and crack cocaine to self-medi-
cate the symptoms of physical and mental health problems
(Klee and Reid 1998a, 1998b; Fountain and Howes 2002;
Homeless Link 2014), SCRA users identified a range of
physical and mental health harms that were often directly
attributed to SCRA dependency and addiction. In addition,
the rapid build-up of tolerance reported by users resulted in
a range of societal harms, within both the homeless popula-
tion, and wider society. Collectively, it is evident that the
emergence of SCRA use within the homeless population has
made life on the streets more unpredictable and hazardous.
With this set of harms in mind, it is clear that there needs
to be a response to the use of SCRAs within the homeless
population. Whether this response should take the form of
further legislative change, or alternatively, a change in ser-
vice approach will now be discussed.
In contrast to legislation that has been introduced to
restrict the use and supply of SCRAs (Department of Justice
and Equality 2010; Malczewski 2011; Parliamentary Counsel
Office 2013; Home Office 2016), it has been argued that one
of the solutions to the use of SCRAs within the homeless
population is to decriminalize or regulate cannabis (Nutt
2017; Transform 2018). The rationale being that if cannabis
were no longer illegal, then SCRA users would switch back to
using cannabis. These arguments are based on the premise
that countries such as the Netherlands and Portugal, which
have more progressive cannabis policies, have very low
reported levels of SCRA use among both the general popula-
tion and vulnerable populations (European Commission 2011,
2014; EMCDDA 2018a, 2018c). Our findings challenge this
ADDICTION RESEARCH & THEORY 7
policy proposal. What is abundantly clear from the homeless
user narratives in this study is that the motivations for SCRA
use are clearly distinct from those associated with the recre-
ational use of cannabis, and serve specific functions in the
context of homelessness. As such, we assert that cannabis pol-
icy reform will have limited impact on SCRA use within the
homeless population. At the other extreme, there are increas-
ing calls for SCRAs to be classified as Class A substances, like
heroin and cocaine (House of Commons 2018). While the
individual and societal harms of SCRAs reported in this study
are comparable to those associated with heroin (Parker and
Newcombe 1987; Pearson 1987; Parker et al. 1988), we caution
against the temptation to reclassify SCRAs. Not only has it
been found that there is no correlation between the
‘toughness’ of a country’s substance use legislation and the
extent of use (Home Office 2014; Stevens 2019), but reclassify-
ing SCRAs could potentially increase the harms associated
with their use (Hammersley 2010; Dargan et al. 2011).
Considering the limitations and potential problems associ-
ated with further legislative change, we argue that a more
appropriate and effective way to address the use of SCRAs
within homeless populations is through the development of a
service response that better meets the needs of homeless
SCRA users, and reduces the harms that we have identified in
this article. Current public health guidance suggests that,
when it comes to managing dependent use of SCRAs, practi-
tioners should ‘adopt the evidence-based approaches used for
other drugs – particularly natural cannabis’ (Abdulrahim and
Bowden-Jones 2016, p. 13). This approach was informed by
the view that, when they first became popular, SCRAs were
perceived as a relatively harmless and legal alternative to nat-
ural cannabis (Blackman and Bradley 2017). Our findings
contest this current guidance, with users recounting harms
more aligned with dependent heroin use than cannabis use
(Parker and Newcombe 1987; Pearson 1987; Parker et al.
1988; Diplock et al. 2012). With this in mind, medically super-
vised community detox and in-patient rehabilitation needs to
be readily available to dependent SCRA users (Ralphs and
Gray 2017). Furthermore, in light of the widely reported
impact of SCRAs on users’ mental health, it is imperative that
existing treatment services have the capabilities to address the
co-existence of mental health problems and substance use. In
our view, this tailored service response would provide a holis-
tic and more effective solution to SCRA use within the home-
less population than further legislative change.
These findings have implications for future research agen-
das. This research adopted a purposive sampling strategy
that targeted current/recent SCRA users. For a more accur-
ate estimate of prevalence, there would be value in conduct-
ing research with a representative sample of the homeless
population. Furthermore, this article is based on research
within the homeless population in one city in the UK.
While there is no reason to expect different findings in other
UK cities, it would be worthwhile conducting studies of
SCRA use within the homeless population in other cities,
both in the UK and around the world. Finally, the reported
detrimental relationship between SCRAs and users’ mental
health is an area that warrants further investigation.
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